Abbmira Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Angel
  • (Announced)

  • Latest Deal Amount
  • $995K

  • Investors
  • 3

Abbmira Therapeutics General Information

Description

Operator of a biotechnology company intended to fine-tune native immunity to treat difficult tumors and chronic diseases. The company offers investigational compounds that target and repolarize macrophages towards an antitumor state, enabling healthcare providers to address challenging medical conditions with innovative treatments.

Contact Information

Website
www.abbmira.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Oetlingerstrasse 150
  • 4057 Basel
  • Switzerland
+41 077
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Oetlingerstrasse 150
  • 4057 Basel
  • Switzerland
+41 077

Abbmira Therapeutics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abbmira Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 03-Dec-2025 $995K Announced Startup
3. Grant 01-Mar-2026 Completed Startup
2. Grant 28-Jan-2025 $11K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Abbmira Therapeutics’s complete valuation and funding history, request access »

Abbmira Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abbmira Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosuisse Government
Venture Kick Accelerator/Incubator
Swiss-Israel Lean Launchpad Accelerator/Incubator
To view Abbmira Therapeutics’s complete investors history, request access »

Abbmira Therapeutics FAQs

  • When was Abbmira Therapeutics founded?

    Abbmira Therapeutics was founded in 2024.

  • Where is Abbmira Therapeutics headquartered?

    Abbmira Therapeutics is headquartered in Basel, Switzerland.

  • What is the size of Abbmira Therapeutics?

    Abbmira Therapeutics has 3 total employees.

  • What industry is Abbmira Therapeutics in?

    Abbmira Therapeutics’s primary industry is Biotechnology.

  • Is Abbmira Therapeutics a private or public company?

    Abbmira Therapeutics is a Private company.

  • What is Abbmira Therapeutics’s current revenue?

    The current revenue for Abbmira Therapeutics is .

  • Who are Abbmira Therapeutics’s investors?

    Innosuisse, Venture Kick, and Swiss-Israel Lean Launchpad have invested in Abbmira Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process